Particle.news

Download on the App Store

CDC Vaccine Advisers to Proceed After Misleading Thimerosal Study Citation

Members appointed by Health Secretary Robert F. Kennedy Jr. will decide whether to limit mercury preservative in some flu shot vials despite lawmakers’ protests

A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014.    REUTERS/Tami Chappell/File Photo
The entrance to the Centers for Disease Control and Prevention is seen, Tuesday, April 19, 2022, in Atlanta. A decision by a federal judge in Florida to throw out a national mask mandate for public transportation across the U.S. created a confusing patchwork of rules for passengers. The CDC recently extended the mandate, but the court decision put the mandate on hold. (AP Photo/Ron Harris)
Image
Image

Overview

  • Lyn Redwood’s presentation initially cited a non-existent 2008 Neurotoxicology study and was revised by the CDC to remove the incorrect reference
  • Senators Bill Cassidy and Patty Murray have urged postponement of the June 25-26 meeting over concerns about the panel’s new membership and absence of a CDC director
  • In early June, Kennedy dismissed all 17 former ACIP members and replaced them with eight advisers, several linked to anti-vaccine positions or legal challenges against manufacturers
  • The panel is expected to vote on whether to restrict thimerosal in some multidose flu vaccine vials despite multiple studies showing no harm at current exposure levels
  • CDC data show that 96% of 2024-25 flu vaccines were thimerosal-free and that multidose vials containing the preservative now account for about 4% of doses